Comprehensive cancer care across all solid tumors and hematological malignancies.
Screening, diagnosis, chemotherapy, hormonal therapy, and targeted agents for all stages.
NSCLC and SCLC management including immunotherapy, targeted therapy, and palliative care.
HPV-related cancers, prevention through vaccination, and comprehensive treatment planning.
Epithelial ovarian tumors, BRCA-related cancers, PARP inhibitors, and maintenance therapy.
Stomach, colon, rectal, pancreatic, and liver cancers — systemic and multidisciplinary approach.
Oral cavity, oropharynx, larynx — concurrent chemoradiation and palliative chemotherapy.
Lymphomas, leukemias, and multiple myeloma — chemotherapy and novel agents.
Kidney, bladder, and prostate cancers including immunotherapy and hormonal treatment.
Uterine cancers including hormone receptor-positive tumors and advanced-stage management.
Diagnosis and systemic treatment of soft tissue sarcomas, osteosarcomas, and Ewing sarcoma — chemotherapy, targeted therapy, and multidisciplinary care.
Age-appropriate cancer treatment for older adults — comprehensive geriatric assessment, treatment optimization, and supportive care.
Genetic counseling, BRCA/Lynch syndrome testing, risk assessment, and surveillance strategies for hereditary cancer predisposition.
Cytotoxic drug regimens tailored to cancer type, stage, and patient fitness.
Checkpoint inhibitors (PD-1/PD-L1, CTLA-4) and combination immune-based strategies.
Precision medicine — EGFR, ALK, HER2, BRCA, and other molecular-targeted agents.
Symptom management, pain control, nutritional support, and quality-of-life optimization.
Get a comprehensive evaluation and personalized treatment plan.
Book Consultation